Vesatolimod
Showing 1 - 12 of 12
HIV-1-infection Trial in Umlazi (Vesatolimod, VRC07523LS, CAP256V2LS)
Recruiting
- HIV-1-infection
- Vesatolimod
- +2 more
-
Umlazi, South AfricaFRESH Clinical Research Site: Females Rising through Education,
Jan 4, 2023
Human Immunodeficiency Virus Type 1 (HIV-1) Infection Trial (Vesatolimod, Cobicistat, Voriconazole)
Not yet recruiting
- Human Immunodeficiency Virus Type 1 (HIV-1) Infection
- Vesatolimod
- +3 more
- (no location specified)
Jul 11, 2022
HIV-1-infection Trial in Brazil, United States (ChAdOx1.tHIVconsv1, ChAdOx1.HIVconsv62, MVA.tHIVconsv3)
Not yet recruiting
- HIV-1-infection
- ChAdOx1.tHIVconsv1
- +7 more
-
San Diego, California
- +11 more
Oct 4, 2023
HIV/AIDS Trial in Spain (ChAdOx1.HTI, MVA.HTI, GS-9620)
Active, not recruiting
- HIV/AIDS
- ChAdOx1.HTI
- +4 more
-
Badalona, Barcelona, Spain
- +8 more
Jul 30, 2021
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ART)
Completed
- HIV-1 Infection
- Vesatolimod
- +2 more
-
Los Angeles, California
- +5 more
Mar 29, 2021
Chronic Hepatitis B Trial in Worldwide (Vesatolimod, Placebo)
Completed
- Chronic Hepatitis B
- Vesatolimod
- Placebo
-
Los Angeles, California
- +22 more
Sep 22, 2020
HIV-1 Infection Trial in United States (Vesatolimod, Placebo, ARV regimen)
Completed
- HIV-1 Infection
- Vesatolimod
- +2 more
-
Los Angeles, California
- +7 more
Feb 7, 2020
Hepatitis B Trial in Worldwide (Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts GS-9620)
Completed
- Hepatitis B
- Single Ascending Dose (SAD) Cohorts GS-9620
- Multiple Ascending Dose (MAD) Cohorts GS-9620
-
Phoenix, Arizona
- +19 more
Dec 18, 2013
Hepatitis B, HBV Trial in Worldwide (Single Ascending Dose (SAD) Cohorts GS-9620, Multiple Ascending Dose (MAD) Cohorts)
Completed
- Hepatitis B
- HBV
- Single Ascending Dose (SAD) Cohorts GS-9620
- Multiple Ascending Dose (MAD) Cohorts
-
Phoenix, Arizona
- +22 more
Nov 13, 2013
Hepatitis C Trial in Puerto Rico, United States (Single Ascending Dose Cohorts GS-9620, Multiple Ascending Dose Cohorts GS-9620)
Completed
- Hepatitis C
- Single Ascending Dose Cohorts GS-9620
- Multiple Ascending Dose Cohorts GS-9620
-
Little Rock, Arkansas
- +10 more
Aug 12, 2013